Global Lung Cancer Diagnostic And Screening Market Research Report 2026(Status and Outlook)
The Lung Cancer Diagnostic and Screening market is experiencing significant growth and is expected to continue to expand in the coming years. Lung cancer is a major global health concern, and early detection and accurate diagnosis are crucial for improving patient outcomes.One major trend in the Lung Cancer Diagnostic and Screening market is the increasing adoption of advanced imaging technologies for lung cancer detection. Technologies such as computed tomography (CT) scans and positron emission tomography (PET) scans are widely used for screening and diagnosing lung cancer. These imaging techniques provide detailed images of the lungs, allowing healthcare professionals to detect lung nodules or tumors at an early stage.
The global Lung Cancer Diagnostic And Screening market size was estimated at USD 83.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Lung Cancer Diagnostic And Screening market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Lung Cancer Diagnostic And Screening market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Lung Cancer Diagnostic And Screening market.
Global Lung Cancer Diagnostic And Screening Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
F.Hoffmann-La Roche AG
Bristol-Myers Squibb Company
Thermo Fisher Scientific
AstraZeneca Plc
Abbott Laboratories
Medtronic Plc
Danaher Corporation
Siemens Healthcare GmbH
FUJIFILM Corporation
KoninklijikePhilips N.V.
GE Healthcare Bio Sciences AB
Quest Diagnostics lIncorporated
Agilent Technologies lnc
Qiagen Inc.
Myriad Genetic Laboratories Inc.
NeoGenomics Laboratories Inc
Canon MedicalSystems Corporation
Eon Health Inc
Market Segmentation (by Type)
Instrument
Consumables and Accessories
Market Segmentation (by Application)
Hospital
Independent Diagnostic Laboratory
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Lung Cancer Diagnostic And Screening Market
Overview of the regional outlook of the Lung Cancer Diagnostic And Screening Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostic And Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lung Cancer Diagnostic And Screening, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Lung Cancer Diagnostic And Screening market size was estimated at USD 83.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Lung Cancer Diagnostic And Screening market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Lung Cancer Diagnostic And Screening market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Lung Cancer Diagnostic And Screening market.
Global Lung Cancer Diagnostic And Screening Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
F.Hoffmann-La Roche AG
Bristol-Myers Squibb Company
Thermo Fisher Scientific
AstraZeneca Plc
Abbott Laboratories
Medtronic Plc
Danaher Corporation
Siemens Healthcare GmbH
FUJIFILM Corporation
KoninklijikePhilips N.V.
GE Healthcare Bio Sciences AB
Quest Diagnostics lIncorporated
Agilent Technologies lnc
Qiagen Inc.
Myriad Genetic Laboratories Inc.
NeoGenomics Laboratories Inc
Canon MedicalSystems Corporation
Eon Health Inc
Market Segmentation (by Type)
Instrument
Consumables and Accessories
Market Segmentation (by Application)
Hospital
Independent Diagnostic Laboratory
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Lung Cancer Diagnostic And Screening Market
Overview of the regional outlook of the Lung Cancer Diagnostic And Screening Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostic And Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lung Cancer Diagnostic And Screening, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic And Screening
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic And Screening Segment by Type
1.2.2 Lung Cancer Diagnostic And Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Diagnostic And Screening Product Life Cycle
3.3 Global Lung Cancer Diagnostic And Screening Revenue Market Share by Company (2020-2025)
3.4 Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Lung Cancer Diagnostic And Screening Market Competitive Situation and Trends
3.6.1 Lung Cancer Diagnostic And Screening Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Diagnostic And Screening Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTIC AND SCREENING VALUE CHAIN ANALYSIS
4.1 Lung Cancer Diagnostic And Screening Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTIC AND SCREENING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Lung Cancer Diagnostic And Screening Market Porter's Five Forces Analysis
6 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic And Screening Market by Type (2020-2025)
6.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2021-2025)
7 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Application (2020-2025)
7.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2021-2025)
8 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostic And Screening Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostic And Screening Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostic And Screening Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Basic Information
9.1.2 Pfizer Lung Cancer Diagnostic And Screening Product Overview
9.1.3 Pfizer Lung Cancer Diagnostic And Screening Product Market Performance
9.1.4 Pfizer SWOT Analysis
9.1.5 Pfizer Business Overview
9.1.6 Pfizer Recent Developments
9.2 F.Hoffmann-La Roche AG
9.2.1 F.Hoffmann-La Roche AG Basic Information
9.2.2 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
9.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Market Performance
9.2.4 F.Hoffmann-La Roche AG SWOT Analysis
9.2.5 F.Hoffmann-La Roche AG Business Overview
9.2.6 F.Hoffmann-La Roche AG Recent Developments
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company Basic Information
9.3.2 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
9.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Market Performance
9.3.4 Bristol-Myers Squibb Company SWOT Analysis
9.3.5 Bristol-Myers Squibb Company Business Overview
9.3.6 Bristol-Myers Squibb Company Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Basic Information
9.4.2 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
9.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 AstraZeneca Plc
9.5.1 AstraZeneca Plc Basic Information
9.5.2 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
9.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.5.4 AstraZeneca Plc Business Overview
9.5.5 AstraZeneca Plc Recent Developments
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Basic Information
9.6.2 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
9.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Market Performance
9.6.4 Abbott Laboratories Business Overview
9.6.5 Abbott Laboratories Recent Developments
9.7 Medtronic Plc
9.7.1 Medtronic Plc Basic Information
9.7.2 Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
9.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.7.4 Medtronic Plc Business Overview
9.7.5 Medtronic Plc Recent Developments
9.8 Danaher Corporation
9.8.1 Danaher Corporation Basic Information
9.8.2 Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
9.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.8.4 Danaher Corporation Business Overview
9.8.5 Danaher Corporation Recent Developments
9.9 Siemens Healthcare GmbH
9.9.1 Siemens Healthcare GmbH Basic Information
9.9.2 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
9.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Market Performance
9.9.4 Siemens Healthcare GmbH Business Overview
9.9.5 Siemens Healthcare GmbH Recent Developments
9.10 FUJIFILM Corporation
9.10.1 FUJIFILM Corporation Basic Information
9.10.2 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
9.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.10.4 FUJIFILM Corporation Business Overview
9.10.5 FUJIFILM Corporation Recent Developments
9.11 KoninklijikePhilips N.V.
9.11.1 KoninklijikePhilips N.V. Basic Information
9.11.2 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
9.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Market Performance
9.11.4 KoninklijikePhilips N.V. Business Overview
9.11.5 KoninklijikePhilips N.V. Recent Developments
9.12 GE Healthcare Bio Sciences AB
9.12.1 GE Healthcare Bio Sciences AB Basic Information
9.12.2 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
9.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Market Performance
9.12.4 GE Healthcare Bio Sciences AB Business Overview
9.12.5 GE Healthcare Bio Sciences AB Recent Developments
9.13 Quest Diagnostics lIncorporated
9.13.1 Quest Diagnostics lIncorporated Basic Information
9.13.2 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
9.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Market Performance
9.13.4 Quest Diagnostics lIncorporated Business Overview
9.13.5 Quest Diagnostics lIncorporated Recent Developments
9.14 Agilent Technologies lnc
9.14.1 Agilent Technologies lnc Basic Information
9.14.2 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
9.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Market Performance
9.14.4 Agilent Technologies lnc Business Overview
9.14.5 Agilent Technologies lnc Recent Developments
9.15 Qiagen Inc.
9.15.1 Qiagen Inc. Basic Information
9.15.2 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
9.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.15.4 Qiagen Inc. Business Overview
9.15.5 Qiagen Inc. Recent Developments
9.16 Myriad Genetic Laboratories Inc.
9.16.1 Myriad Genetic Laboratories Inc. Basic Information
9.16.2 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
9.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.16.4 Myriad Genetic Laboratories Inc. Business Overview
9.16.5 Myriad Genetic Laboratories Inc. Recent Developments
9.17 NeoGenomics Laboratories Inc
9.17.1 NeoGenomics Laboratories Inc Basic Information
9.17.2 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
9.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.17.4 NeoGenomics Laboratories Inc Business Overview
9.17.5 NeoGenomics Laboratories Inc Recent Developments
9.18 Canon MedicalSystems Corporation
9.18.1 Canon MedicalSystems Corporation Basic Information
9.18.2 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
9.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.18.4 Canon MedicalSystems Corporation Business Overview
9.18.5 Canon MedicalSystems Corporation Recent Developments
9.19 Eon Health Inc
9.19.1 Eon Health Inc Basic Information
9.19.2 Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
9.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.19.4 Eon Health Inc Business Overview
9.19.5 Eon Health Inc Recent Developments
10 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET FORECAST BY REGION
10.1 Global Lung Cancer Diagnostic And Screening Market Size Forecast
10.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region
10.2.4 South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Diagnostic And Screening by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Lung Cancer Diagnostic And Screening Market Forecast by Type (2026-2035)
11.1.1 Global Lung Cancer Diagnostic And Screening Market Size Forecast by Type (2026-2035)
11.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Application (2026-2035)
11.2.1 Global Lung Cancer Diagnostic And Screening Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic And Screening
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic And Screening Segment by Type
1.2.2 Lung Cancer Diagnostic And Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Diagnostic And Screening Product Life Cycle
3.3 Global Lung Cancer Diagnostic And Screening Revenue Market Share by Company (2020-2025)
3.4 Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Lung Cancer Diagnostic And Screening Market Competitive Situation and Trends
3.6.1 Lung Cancer Diagnostic And Screening Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Diagnostic And Screening Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTIC AND SCREENING VALUE CHAIN ANALYSIS
4.1 Lung Cancer Diagnostic And Screening Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTIC AND SCREENING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Lung Cancer Diagnostic And Screening Market Porter's Five Forces Analysis
6 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic And Screening Market by Type (2020-2025)
6.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2021-2025)
7 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Application (2020-2025)
7.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2021-2025)
8 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostic And Screening Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostic And Screening Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostic And Screening Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Basic Information
9.1.2 Pfizer Lung Cancer Diagnostic And Screening Product Overview
9.1.3 Pfizer Lung Cancer Diagnostic And Screening Product Market Performance
9.1.4 Pfizer SWOT Analysis
9.1.5 Pfizer Business Overview
9.1.6 Pfizer Recent Developments
9.2 F.Hoffmann-La Roche AG
9.2.1 F.Hoffmann-La Roche AG Basic Information
9.2.2 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
9.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Market Performance
9.2.4 F.Hoffmann-La Roche AG SWOT Analysis
9.2.5 F.Hoffmann-La Roche AG Business Overview
9.2.6 F.Hoffmann-La Roche AG Recent Developments
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company Basic Information
9.3.2 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
9.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Market Performance
9.3.4 Bristol-Myers Squibb Company SWOT Analysis
9.3.5 Bristol-Myers Squibb Company Business Overview
9.3.6 Bristol-Myers Squibb Company Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Basic Information
9.4.2 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
9.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 AstraZeneca Plc
9.5.1 AstraZeneca Plc Basic Information
9.5.2 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
9.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.5.4 AstraZeneca Plc Business Overview
9.5.5 AstraZeneca Plc Recent Developments
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Basic Information
9.6.2 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
9.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Market Performance
9.6.4 Abbott Laboratories Business Overview
9.6.5 Abbott Laboratories Recent Developments
9.7 Medtronic Plc
9.7.1 Medtronic Plc Basic Information
9.7.2 Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
9.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.7.4 Medtronic Plc Business Overview
9.7.5 Medtronic Plc Recent Developments
9.8 Danaher Corporation
9.8.1 Danaher Corporation Basic Information
9.8.2 Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
9.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.8.4 Danaher Corporation Business Overview
9.8.5 Danaher Corporation Recent Developments
9.9 Siemens Healthcare GmbH
9.9.1 Siemens Healthcare GmbH Basic Information
9.9.2 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
9.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Market Performance
9.9.4 Siemens Healthcare GmbH Business Overview
9.9.5 Siemens Healthcare GmbH Recent Developments
9.10 FUJIFILM Corporation
9.10.1 FUJIFILM Corporation Basic Information
9.10.2 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
9.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.10.4 FUJIFILM Corporation Business Overview
9.10.5 FUJIFILM Corporation Recent Developments
9.11 KoninklijikePhilips N.V.
9.11.1 KoninklijikePhilips N.V. Basic Information
9.11.2 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
9.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Market Performance
9.11.4 KoninklijikePhilips N.V. Business Overview
9.11.5 KoninklijikePhilips N.V. Recent Developments
9.12 GE Healthcare Bio Sciences AB
9.12.1 GE Healthcare Bio Sciences AB Basic Information
9.12.2 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
9.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Market Performance
9.12.4 GE Healthcare Bio Sciences AB Business Overview
9.12.5 GE Healthcare Bio Sciences AB Recent Developments
9.13 Quest Diagnostics lIncorporated
9.13.1 Quest Diagnostics lIncorporated Basic Information
9.13.2 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
9.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Market Performance
9.13.4 Quest Diagnostics lIncorporated Business Overview
9.13.5 Quest Diagnostics lIncorporated Recent Developments
9.14 Agilent Technologies lnc
9.14.1 Agilent Technologies lnc Basic Information
9.14.2 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
9.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Market Performance
9.14.4 Agilent Technologies lnc Business Overview
9.14.5 Agilent Technologies lnc Recent Developments
9.15 Qiagen Inc.
9.15.1 Qiagen Inc. Basic Information
9.15.2 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
9.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.15.4 Qiagen Inc. Business Overview
9.15.5 Qiagen Inc. Recent Developments
9.16 Myriad Genetic Laboratories Inc.
9.16.1 Myriad Genetic Laboratories Inc. Basic Information
9.16.2 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
9.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.16.4 Myriad Genetic Laboratories Inc. Business Overview
9.16.5 Myriad Genetic Laboratories Inc. Recent Developments
9.17 NeoGenomics Laboratories Inc
9.17.1 NeoGenomics Laboratories Inc Basic Information
9.17.2 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
9.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.17.4 NeoGenomics Laboratories Inc Business Overview
9.17.5 NeoGenomics Laboratories Inc Recent Developments
9.18 Canon MedicalSystems Corporation
9.18.1 Canon MedicalSystems Corporation Basic Information
9.18.2 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
9.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.18.4 Canon MedicalSystems Corporation Business Overview
9.18.5 Canon MedicalSystems Corporation Recent Developments
9.19 Eon Health Inc
9.19.1 Eon Health Inc Basic Information
9.19.2 Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
9.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.19.4 Eon Health Inc Business Overview
9.19.5 Eon Health Inc Recent Developments
10 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET FORECAST BY REGION
10.1 Global Lung Cancer Diagnostic And Screening Market Size Forecast
10.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region
10.2.4 South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Diagnostic And Screening by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Lung Cancer Diagnostic And Screening Market Forecast by Type (2026-2035)
11.1.1 Global Lung Cancer Diagnostic And Screening Market Size Forecast by Type (2026-2035)
11.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Application (2026-2035)
11.2.1 Global Lung Cancer Diagnostic And Screening Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Lung Cancer Diagnostic And Screening Market Size by Type (M USD)
Table 4. Global Lung Cancer Diagnostic And Screening Market Size by Application
Table 5. Lung Cancer Diagnostic And Screening Market Size Comparison by Region (M USD)
Table 6. Global Lung Cancer Diagnostic And Screening Revenue (M USD) by Company (2020-2025)
Table 7. Global Lung Cancer Diagnostic And Screening Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic And Screening as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Lung Cancer Diagnostic And Screening Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Lung Cancer Diagnostic And Screening Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Lung Cancer Diagnostic And Screening Market Size by Type (M USD)
Table 22. Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Type (2020-2025)
Table 23. Global Lung Cancer Diagnostic And Screening Market Share by Type (2020-2025)
Table 24. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2021-2025)
Table 25. Global Lung Cancer Diagnostic And Screening Market Size by Application
Table 26. Global Lung Cancer Diagnostic And Screening Market Size by Application (2020-2025) & (M USD)
Table 27. Global Lung Cancer Diagnostic And Screening Market Share by Application (2020-2025)
Table 28. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2021-2025)
Table 29. Global Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025) & (M USD)
Table 30. Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region (2020-2025)
Table 31. North America Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025) & (M USD)
Table 34. South America Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025) & (M USD)
Table 36. Pfizer Basic Information
Table 37. Pfizer Lung Cancer Diagnostic And Screening Product Overview
Table 38. Pfizer Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Pfizer SWOT Analysis
Table 40. Pfizer Business Overview
Table 41. Pfizer Recent Developments
Table 42. F.Hoffmann-La Roche AG Basic Information
Table 43. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
Table 44. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 45. F.Hoffmann-La Roche AG SWOT Analysis
Table 46. F.Hoffmann-La Roche AG Business Overview
Table 47. F.Hoffmann-La Roche AG Recent Developments
Table 48. Bristol-Myers Squibb Company Basic Information
Table 49. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
Table 50. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Bristol-Myers Squibb Company SWOT Analysis
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company Recent Developments
Table 54. Thermo Fisher Scientific Basic Information
Table 55. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
Table 56. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. AstraZeneca Plc Basic Information
Table 60. AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
Table 61. AstraZeneca Plc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 62. AstraZeneca Plc Business Overview
Table 63. AstraZeneca Plc Recent Developments
Table 64. Abbott Laboratories Basic Information
Table 65. Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
Table 66. Abbott Laboratories Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Recent Developments
Table 69. Medtronic Plc Basic Information
Table 70. Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
Table 71. Medtronic Plc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Medtronic Plc Business Overview
Table 73. Medtronic Plc Recent Developments
Table 74. Danaher Corporation Basic Information
Table 75. Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 76. Danaher Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Danaher Corporation Business Overview
Table 78. Danaher Corporation Recent Developments
Table 79. Siemens Healthcare GmbH Basic Information
Table 80. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
Table 81. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Siemens Healthcare GmbH Business Overview
Table 83. Siemens Healthcare GmbH Recent Developments
Table 84. FUJIFILM Corporation Basic Information
Table 85. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 86. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 87. FUJIFILM Corporation Business Overview
Table 88. FUJIFILM Corporation Recent Developments
Table 89. KoninklijikePhilips N.V. Basic Information
Table 90. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
Table 91. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 92. KoninklijikePhilips N.V. Business Overview
Table 93. KoninklijikePhilips N.V. Recent Developments
Table 94. GE Healthcare Bio Sciences AB Basic Information
Table 95. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
Table 96. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 97. GE Healthcare Bio Sciences AB Business Overview
Table 98. GE Healthcare Bio Sciences AB Recent Developments
Table 99. Quest Diagnostics lIncorporated Basic Information
Table 100. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
Table 101. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Quest Diagnostics lIncorporated Business Overview
Table 103. Quest Diagnostics lIncorporated Recent Developments
Table 104. Agilent Technologies lnc Basic Information
Table 105. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
Table 106. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Agilent Technologies lnc Business Overview
Table 108. Agilent Technologies lnc Recent Developments
Table 109. Qiagen Inc. Basic Information
Table 110. Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
Table 111. Qiagen Inc. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Qiagen Inc. Business Overview
Table 113. Qiagen Inc. Recent Developments
Table 114. Myriad Genetic Laboratories Inc. Basic Information
Table 115. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
Table 116. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Myriad Genetic Laboratories Inc. Business Overview
Table 118. Myriad Genetic Laboratories Inc. Recent Developments
Table 119. NeoGenomics Laboratories Inc Basic Information
Table 120. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
Table 121. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 122. NeoGenomics Laboratories Inc Business Overview
Table 123. NeoGenomics Laboratories Inc Recent Developments
Table 124. Canon MedicalSystems Corporation Basic Information
Table 125. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 126. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Canon MedicalSystems Corporation Business Overview
Table 128. Canon MedicalSystems Corporation Recent Developments
Table 129. Eon Health Inc Basic Information
Table 130. Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
Table 131. Eon Health Inc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 132. Eon Health Inc Business Overview
Table 133. Eon Health Inc Recent Developments
Table 134. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 135. North America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Type (2026-2035) & (M USD)
Table 141. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Lung Cancer Diagnostic And Screening Market Size by Type (M USD)
Table 4. Global Lung Cancer Diagnostic And Screening Market Size by Application
Table 5. Lung Cancer Diagnostic And Screening Market Size Comparison by Region (M USD)
Table 6. Global Lung Cancer Diagnostic And Screening Revenue (M USD) by Company (2020-2025)
Table 7. Global Lung Cancer Diagnostic And Screening Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic And Screening as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Lung Cancer Diagnostic And Screening Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Lung Cancer Diagnostic And Screening Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Lung Cancer Diagnostic And Screening Market Size by Type (M USD)
Table 22. Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Type (2020-2025)
Table 23. Global Lung Cancer Diagnostic And Screening Market Share by Type (2020-2025)
Table 24. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2021-2025)
Table 25. Global Lung Cancer Diagnostic And Screening Market Size by Application
Table 26. Global Lung Cancer Diagnostic And Screening Market Size by Application (2020-2025) & (M USD)
Table 27. Global Lung Cancer Diagnostic And Screening Market Share by Application (2020-2025)
Table 28. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2021-2025)
Table 29. Global Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025) & (M USD)
Table 30. Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region (2020-2025)
Table 31. North America Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025) & (M USD)
Table 34. South America Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025) & (M USD)
Table 36. Pfizer Basic Information
Table 37. Pfizer Lung Cancer Diagnostic And Screening Product Overview
Table 38. Pfizer Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Pfizer SWOT Analysis
Table 40. Pfizer Business Overview
Table 41. Pfizer Recent Developments
Table 42. F.Hoffmann-La Roche AG Basic Information
Table 43. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
Table 44. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 45. F.Hoffmann-La Roche AG SWOT Analysis
Table 46. F.Hoffmann-La Roche AG Business Overview
Table 47. F.Hoffmann-La Roche AG Recent Developments
Table 48. Bristol-Myers Squibb Company Basic Information
Table 49. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
Table 50. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Bristol-Myers Squibb Company SWOT Analysis
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company Recent Developments
Table 54. Thermo Fisher Scientific Basic Information
Table 55. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
Table 56. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. AstraZeneca Plc Basic Information
Table 60. AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
Table 61. AstraZeneca Plc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 62. AstraZeneca Plc Business Overview
Table 63. AstraZeneca Plc Recent Developments
Table 64. Abbott Laboratories Basic Information
Table 65. Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
Table 66. Abbott Laboratories Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Recent Developments
Table 69. Medtronic Plc Basic Information
Table 70. Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
Table 71. Medtronic Plc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Medtronic Plc Business Overview
Table 73. Medtronic Plc Recent Developments
Table 74. Danaher Corporation Basic Information
Table 75. Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 76. Danaher Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Danaher Corporation Business Overview
Table 78. Danaher Corporation Recent Developments
Table 79. Siemens Healthcare GmbH Basic Information
Table 80. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
Table 81. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Siemens Healthcare GmbH Business Overview
Table 83. Siemens Healthcare GmbH Recent Developments
Table 84. FUJIFILM Corporation Basic Information
Table 85. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 86. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 87. FUJIFILM Corporation Business Overview
Table 88. FUJIFILM Corporation Recent Developments
Table 89. KoninklijikePhilips N.V. Basic Information
Table 90. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
Table 91. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 92. KoninklijikePhilips N.V. Business Overview
Table 93. KoninklijikePhilips N.V. Recent Developments
Table 94. GE Healthcare Bio Sciences AB Basic Information
Table 95. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
Table 96. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 97. GE Healthcare Bio Sciences AB Business Overview
Table 98. GE Healthcare Bio Sciences AB Recent Developments
Table 99. Quest Diagnostics lIncorporated Basic Information
Table 100. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
Table 101. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Quest Diagnostics lIncorporated Business Overview
Table 103. Quest Diagnostics lIncorporated Recent Developments
Table 104. Agilent Technologies lnc Basic Information
Table 105. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
Table 106. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Agilent Technologies lnc Business Overview
Table 108. Agilent Technologies lnc Recent Developments
Table 109. Qiagen Inc. Basic Information
Table 110. Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
Table 111. Qiagen Inc. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Qiagen Inc. Business Overview
Table 113. Qiagen Inc. Recent Developments
Table 114. Myriad Genetic Laboratories Inc. Basic Information
Table 115. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
Table 116. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Myriad Genetic Laboratories Inc. Business Overview
Table 118. Myriad Genetic Laboratories Inc. Recent Developments
Table 119. NeoGenomics Laboratories Inc Basic Information
Table 120. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
Table 121. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 122. NeoGenomics Laboratories Inc Business Overview
Table 123. NeoGenomics Laboratories Inc Recent Developments
Table 124. Canon MedicalSystems Corporation Basic Information
Table 125. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 126. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Canon MedicalSystems Corporation Business Overview
Table 128. Canon MedicalSystems Corporation Recent Developments
Table 129. Eon Health Inc Basic Information
Table 130. Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
Table 131. Eon Health Inc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2020-2025)
Table 132. Eon Health Inc Business Overview
Table 133. Eon Health Inc Recent Developments
Table 134. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 135. North America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Type (2026-2035) & (M USD)
Table 141. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Lung Cancer Diagnostic And Screening
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostic And Screening Market Size (M USD), 2025-2035
Figure 5. Global Lung Cancer Diagnostic And Screening Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Lung Cancer Diagnostic And Screening Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Lung Cancer Diagnostic And Screening Product Life Cycle
Figure 12. Global Lung Cancer Diagnostic And Screening Revenue Share by Company in 2025
Figure 13. Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostic And Screening Revenue in 2025
Figure 15. Value Chain Map of Lung Cancer Diagnostic And Screening
Figure 16. Global Lung Cancer Diagnostic And Screening Market PEST Analysis
Figure 17. Global Lung Cancer Diagnostic And Screening Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Lung Cancer Diagnostic And Screening Market Share by Type
Figure 20. Market Share of Lung Cancer Diagnostic And Screening by Type (2020-2025)
Figure 21. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Diagnostic And Screening Market Share by Application
Figure 24. Global Lung Cancer Diagnostic And Screening Market Share by Application (2020-2025)
Figure 25. Global Lung Cancer Diagnostic And Screening Market Share by Application in 2024
Figure 26. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region (2020-2025)
Figure 28. North America Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2024
Figure 30. U.S. Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Lung Cancer Diagnostic And Screening Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Lung Cancer Diagnostic And Screening Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Lung Cancer Diagnostic And Screening Market Share by Country in 2024
Figure 35. Germany Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Lung Cancer Diagnostic And Screening Market Size Market Share by Region in 2024
Figure 42. China Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 48. South America Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2024
Figure 49. Brazil Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Lung Cancer Diagnostic And Screening Market Share Forecast by Type (2026-2035)
Figure 61. Global Lung Cancer Diagnostic And Screening Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Lung Cancer Diagnostic And Screening
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostic And Screening Market Size (M USD), 2025-2035
Figure 5. Global Lung Cancer Diagnostic And Screening Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Lung Cancer Diagnostic And Screening Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Lung Cancer Diagnostic And Screening Product Life Cycle
Figure 12. Global Lung Cancer Diagnostic And Screening Revenue Share by Company in 2025
Figure 13. Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostic And Screening Revenue in 2025
Figure 15. Value Chain Map of Lung Cancer Diagnostic And Screening
Figure 16. Global Lung Cancer Diagnostic And Screening Market PEST Analysis
Figure 17. Global Lung Cancer Diagnostic And Screening Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Lung Cancer Diagnostic And Screening Market Share by Type
Figure 20. Market Share of Lung Cancer Diagnostic And Screening by Type (2020-2025)
Figure 21. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Diagnostic And Screening Market Share by Application
Figure 24. Global Lung Cancer Diagnostic And Screening Market Share by Application (2020-2025)
Figure 25. Global Lung Cancer Diagnostic And Screening Market Share by Application in 2024
Figure 26. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region (2020-2025)
Figure 28. North America Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2024
Figure 30. U.S. Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Lung Cancer Diagnostic And Screening Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Lung Cancer Diagnostic And Screening Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Lung Cancer Diagnostic And Screening Market Share by Country in 2024
Figure 35. Germany Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Lung Cancer Diagnostic And Screening Market Size Market Share by Region in 2024
Figure 42. China Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 48. South America Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2024
Figure 49. Brazil Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Lung Cancer Diagnostic And Screening Market Share Forecast by Type (2026-2035)
Figure 61. Global Lung Cancer Diagnostic And Screening Market Share Forecast by Application (2026-2035)
